Literature DB >> 19297023

Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60.

Jurica Arapović1, Tihana Lenac Rovis, Anil Butchi Reddy, Astrid Krmpotić, Stipan Jonjić.   

Abstract

Both human and mouse cytomegalovirus (CMV) encode proteins that inhibit the activation of NK cells by down-regulating the cellular ligands for activating NK cell receptor, NKG2D. MCMV proteins m145, m152 and m155 interfere with the expression of all known NKG2D ligands, MULT-1, RAE-1 family members and H60, respectively, whereas m138 affects the expression of MULT-1 and H60. Here we show that m152 affects the maturation of newly synthesized RAE-1 molecules, but is not sufficient to prevent surface expression of RAE-1varepsilon. We have identified m138 as a main inhibitor of the surface expression of RAE-1varepsilon. In contrast to m152, m138 affects the surface-resident protein leading to its endocytosis, which can be prevented by a dynamin inhibitor. Moreover, we demonstrated that m138 does not need other viral proteins to down-modulate the expression of RAE-1varepsilon.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297023     DOI: 10.1016/j.molimm.2009.02.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  24 in total

Review 1.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Authors:  Irena Slavuljica; Andreas Busche; Marina Babić; Maja Mitrović; Iva Gašparović; Durđica Cekinović; Elitza Markova Car; Ester Pernjak Pugel; Ana Ciković; Vanda Juranić Lisnić; William J Britt; Ulrich Koszinowski; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

3.  Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines.

Authors:  Mark R Schleiss
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

4.  The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses.

Authors:  Andrea I Loewendorf; Lars Steinbrueck; Christoph Peter; Andreas Busche; Chris A Benedict; Penelope C Kay-Jackson
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

5.  Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion.

Authors:  Rui Wang; Kannan Natarajan; Maria Jamela R Revilleza; Lisa F Boyd; Li Zhi; Huaying Zhao; Howard Robinson; David H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 6.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.

Authors:  Philipp Kolb; Steven Sijmons; Matthew R McArdle; Husam Taher; Jennie Womack; Colette Hughes; Abigail Ventura; Michael A Jarvis; Christiane Stahl-Hennig; Scott Hansen; Louis J Picker; Daniel Malouli; Hartmut Hengel; Klaus Früh
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

8.  The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors.

Authors:  Joseph C Sun; Lewis L Lanier
Journal:  Viruses       Date:  2009       Impact factor: 5.048

9.  Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.

Authors:  Jurica Arapovic; Tihana Lenac; Ronald Antulov; Bojan Polic; Zsolt Ruzsics; Leonidas N Carayannopoulos; Ulrich H Koszinowski; Astrid Krmpotic; Stipan Jonjic
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

Review 10.  NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections.

Authors:  Raymond M Welsh; Stephen N Waggoner
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.